Professor, Department of Surgical Oncology University of Texas MD Anderson Cancer Center
General Surgery
Dr. Jeffrey E. Gershenwald, MD
|
|
Give Review
Jeffrey Gershenwald works in the field of General Surgery. He went to Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University has a rank of 18 in research and a 49 in primary care He received awards:"Regional Top Doctor" and "Fellow (FACS)". Doctor Jeffrey E. Gershenwald, MD is also a published doctor. He has 100 publication published. The most recent publication is: Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b ... He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
- Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b ...
- Stemming the rising incidence of melanoma: Calling prevention to action.
- Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
- Biology of advanced uveal melanoma and next steps for clinical therapeutics.
- Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema.
- Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
- Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis.
- The relationship between blood IL-12p40 level and melanoma progression.
- Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations.
- 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case-control Analysis.
- Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell Carcinoma.
- Clinical value of the sentinel-node biopsy in primary cutaneous melanoma.
- Age as a Predictor of Sentinel Node Metastasis among Patients with Localized Melanoma: An Inverse Correlation of Melanoma Mortality and Incidence of Sentinel Node Meta...
- Is Surveillance Imaging Effective for Detecting Surgically Treatable Recurrences in Patients With Melanoma? A Comparative Analysis of Stage-Specific Surveillance Strat...
- Randomized controlled trial of a sun protection intervention for children of melanoma survivors.
- Somatic Mutations in MAP3K5 Attenuate its Pro-Apoptotic Function in Melanoma Through Increased Binding to Thioredoxin.
- Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma.
- Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma.
- Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.
- Age as a prognostic factor in patients with localized melanoma and regional metastases.
- Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: A Phase II trial (CTEP 7190/ Mel47).
- Polymorphisms of Nucleotide Excision Repair Genes Predict Melanoma Survival.
- Variants in melanocortin 1 receptor gene contribute to risk of melanoma - a direct sequencing Analysis in a Texas population.
- Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients.
- The Challenge of Defining Guidelines for Sentinel Lymph Node Biopsy in Patients with Thin Primary Cutaneous Melanomas.
- The Expression of p-STAT3 in Stage IV Melanoma: Risk of CNS Metastasis and Survival.
- Lysophosphatidic Acid Induces Lymphangiogenesis and Interleukin-8 Production in Vitro in Human Lymphatic Endothelial Cells.
- Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.
- NRAS mutation status is an independent prognostic factor in metastatic melanoma.
- Vascular ligand-receptor mapping by direct combinatorial selection in Cancer patients.
- Exon capture Analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.
- Evidence-based treatment of early-stage melanoma.
- Mapping FACT-Melanoma Quality-of-Life Scores to EQ-5D Health Utility Weights.
- Update on the melanoma staging system: The importance of sentinel node staging and primary tumor mitotic rate.
- Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
- Sentinel-lymph-node biopsy for cutaneous melanoma.
- Lymphangiogenesis and hemangiogenesis: potential targets for therapy.
- Cutaneous melanoma: a model to study Cancer metastasis.
- Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer ...
- Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-Analysis.
- Clinical correlates of NRAS and BRAF mutations in primary human melanoma.
- Targeted therapy for melanoma: a primer.
- Sentinel lymph node biopsy for melanoma: critical assessment at its twentieth anniversary.
- Staging and prognosis of cutaneous melanoma.
- Preface. Melanoma.
- Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system.
- Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.
- Conditional survival estimates improve over 5 years for melanoma survivors with node-positive Disease.
- Multivariate Analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.
- Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based Analysis.
- Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.
- Final version of 2009 AJCC melanoma staging and classification.
- Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma.
- Society of surgical oncology fellowship training: where we have been, where we are now, and where we are going.
- Lymph node ratio predicts Disease-specific survival in melanoma patients.
- Sentinel node biopsy and standard of care for melanoma.
- Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.
- Role of sentinel lymph node biopsy in patients with thin melanoma.
- Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
- A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans.
- Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.
- Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and Vascular endothelial growth factor/Vascular endothelial growth factor receptor-2.
- Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma.
- Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire.
- Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study.
- Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III Disease.
- How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)?
- Melanoma Adrenal metastasis: natural history and surgical management.
- Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
- Cost effectiveness of adjuvant interferon in node-positive melanoma.
- Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study.
- Imaging studies in patients with melanoma.
- Quantitative Analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during mela...
- Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma.
- Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
- Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control Analysis.
- Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.
- Ethnic differences among patients with cutaneous melanoma.
- Invasive squamous cell Carcinoma of the skin: defining a high-risk group.
- Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma.
- Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
- Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
- Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous Disease.
- Metastatic melanoma to lymph nodes in patients with unknown primary sites.
- Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
- Activation of stat3 in human melanoma promotes brain metastasis.
- Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.
- Combined-modality therapy for patients with regional nodal metastases from melanoma.
- Segmental neurofibromatosis in association with a large congenital nevus and malignant melanoma.
- In vitro sensitivity to ultraviolet B light and skin Cancer risk: a case-control analysis.
- Automated quantitative Analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction.
- Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients.
- Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
- Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy.
- Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal Disease?
- The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes.
- Management of early-stage cutaneous melanoma.
- A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
Schools
Weill Cornell Medical College
New York Presbyterian HospitalWeill Cornell Med Center
University Tex MD Anderson Canc Center
Procedures Preformed
- Biopsy of Breast
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- Lymph Node Biopsy or Excision
- Percutaneous Tumor Ablation, Liver
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FACS)
Education
-
New York Presbyterian Hospital - Cornell Campus -
Weill Cornell Medical College of Cornell University
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760589162 |
| Last Name Of The Provider | GERSHENWALD |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
|
Dr. Pay Z. Cheng, MD |
|
Dr. Rafael A. Lugo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean N. Vauthey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip R. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Iman Al-Haj, MD |
|
|
Dr. Zachary M. Griffith, MD |
|
|
Dr. Julie L. Holihan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naruhiko Ikoma, MD |
|
|
Dr. Meredith C. Mason, MD |
|
|
Dr. Victor M. Lizarraga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aslam Samar, MD |
|
|
Dr. Richard E. Royal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wayne S. Orr III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward R. Teitel, MD |